{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:13:18Z","timestamp":1793221998544,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T00:00:00Z","timestamp":1152230400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s00213-006-0457-5","type":"journal-article","created":{"date-parts":[[2006,7,7]],"date-time":"2006-07-07T09:06:33Z","timestamp":1152263193000},"page":"268-283","source":"Crossref","is-referenced-by-count":1324,"title":["Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance"],"prefix":"10.1007","volume":"187","author":[{"given":"R. R.","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. A.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,7,7]]},"reference":[{"key":"457_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0893-133X(95)00136-2","volume":"14","author":"HD Abraham","year":"1996","unstructured":"Abraham HD, Aldridge AM, Gogia P (1996) The psychopharmacology of hallucinogens. Neuropsychopharmacology 14:285\u2013298","journal-title":"Neuropsychopharmacology"},{"key":"457_CR2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.npp.1300621","volume":"30","author":"OL Carter","year":"2005","unstructured":"Carter OL, Pettigrew JD, Hasler F, Wallis GM, Liu GB, Hell D, Vollenweider FX (2005) Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Neuropsychopharmacology 30:1154\u20131162","journal-title":"Neuropsychopharmacology"},{"key":"457_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00008877-199406000-00005","volume":"5","author":"LD Chait","year":"1994","unstructured":"Chait LD (1994) Reinforcing and subjective effects of methylphenidate in humans. Behav Pharmacol 5:281\u2013288","journal-title":"Behav Pharmacol"},{"key":"457_CR4","unstructured":"Costa PT, McCrae RR (1992) Revised NEO Personality Inventory (NEO-PI-R) and NEO Five-Factor Inventory (NEO-FFI) professional manual. Psychological Assessment Resources, Odessa, FL"},{"issue":"Suppl 2","key":"457_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-2007-979351","volume":"31","author":"A Dittrich","year":"1998","unstructured":"Dittrich A (1998) The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31(Suppl 2):80\u201384","journal-title":"Pharmacopsychiatry"},{"key":"457_CR6","volume-title":"LSD spirituality and the creative process","author":"M Dobkin de Rios","year":"2003","unstructured":"Dobkin de Rios M, Janiger O (2003) LSD spirituality and the creative process. Park Street, Rochester, VT"},{"key":"457_CR7","first-page":"1","volume":"23","author":"R Doblin","year":"1991","unstructured":"Doblin R (1991) Pahnke\u2019s Good Friday experiment: a long-term follow-up and methodological critique. J Transpers Psychol 23:1\u201328","journal-title":"J Transpers Psychol"},{"key":"457_CR8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00008877-200403000-00007","volume":"15","author":"WE Fantegrossi","year":"2004","unstructured":"Fantegrossi WE, Woods JH, Winger G (2004) Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys. Behav Pharmacol 15:149\u2013157","journal-title":"Behav Pharmacol"},{"key":"457_CR9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002130050860","volume":"142","author":"E Gouzoulis-Mayfrank","year":"1999","unstructured":"Gouzoulis-Mayfrank E, Thelen B, Habermeyer E, Kunert HJ, Kovar KA, Lindenblatt H, Hermle L, Spitzer M, Sass H (1999) Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study. Psychopharmacology (Berl) 142:41\u201350","journal-title":"Psychopharmacology (Berl)"},{"key":"457_CR10","first-page":"1","volume-title":"Advances in substance abuse, vol 1","author":"RR Griffiths","year":"1980","unstructured":"Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol 1. JAI, Greenwich, pp 1\u201390"},{"key":"457_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2466\/pr0.1966.18.1.163","volume":"18","author":"CA Haertzen","year":"1966","unstructured":"Haertzen CA (1966) Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI). Psychol Rep 18:163\u2013194","journal-title":"Psychol Rep"},{"key":"457_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0376-8716(98)00129-X","volume":"53","author":"JH Halpern","year":"1999","unstructured":"Halpern JH, Pope HG (1999) Do hallucinogens cause residual neuropsychological toxicity? Drug Alcohol Depend 53:247\u2013256","journal-title":"Drug Alcohol Depend"},{"key":"457_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler F, Grimberg U, Benz MA, Huber T, Vollenweider FX (2004) Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose\u2013effect study. Psychopharmacology (Berl) 172:145\u2013156","journal-title":"Psychopharmacology (Berl)"},{"key":"457_CR14","first-page":"42","volume":"130","author":"LE Hollister","year":"1961","unstructured":"Hollister LE (1961) Clinical, biochemical and psychologic effects of psilocybin. Arch Int Pharmacodyn Ther 130:42\u201352","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"457_CR15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2307\/1387425","volume":"29","author":"RW Hood Jr","year":"1990","unstructured":"Hood RW Jr, Morris RJ, Watson PJ (1990) Quasi-experimental elicitation of the differential report of mystical experience among intrinsic indiscriminatively pro-religious types. J Sci Study Relig 29:164\u2013172","journal-title":"J Sci Study Relig"},{"key":"457_CR16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/0021-8294.00085","volume":"40","author":"RW Hood Jr","year":"2001","unstructured":"Hood RW Jr, Ghorbani N, Watson PJ, Ghramaleki AF, Bing MN, Davison HK, Morris RJ, Williamson WP (2001) Dimensions of the mysticism scale: confirming the three-factor structure in the United States and Iran. J Sci Study Relig 40:691\u2013705","journal-title":"J Sci Study Relig"},{"key":"457_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00408109","volume":"1","author":"H Isbell","year":"1959","unstructured":"Isbell H (1959) Comparison of the reactions induced by psilocybin and LSD-25 in man. Psychopharmacologia 1:29\u201338","journal-title":"Psychopharmacologia"},{"key":"457_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-642-66612-4_4","volume-title":"Drug addiction","author":"DR Jasinski","year":"1977","unstructured":"Jasinski DR (1977) Assessment of the abuse potential of morphine-like drugs (methods used in man). In: Martin WR (ed) Drug addiction. Springer, Berlin Heidelberg New York, pp 197\u2013258"},{"key":"457_CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1037\/1064-1297.6.4.367","volume":"6","author":"SH Kollins","year":"1998","unstructured":"Kollins SH, Rush CR, Pazzaglia PJ, Ali JA (1998) Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate. Exp Clin Psychopharmacol 6:367\u2013374","journal-title":"Exp Clin Psychopharmacol"},{"key":"457_CR20","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196312000-00007","volume":"137","author":"T Leary","year":"1963","unstructured":"Leary T, Litwin GH, Metzner R (1963) Reactions to psilocybin administered in a supportive environment. J Nerv Ment Dis 137:561\u2013573","journal-title":"J Nerv Ment Dis"},{"key":"457_CR21","volume-title":"Halluzinogene psychische grenzzustande in forschung und psychotherapie","author":"H Leuner","year":"1981","unstructured":"Leuner H (1981) Halluzinogene psychische grenzzustande in forschung und psychotherapie. Hans Huber, Bern"},{"key":"457_CR22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0010-440X(60)80045-4","volume":"1","author":"S Malitz","year":"1960","unstructured":"Malitz S, Esecover H, Wilkens B, Hoch PH (1960) Some observations on psilocybin, a new hallucinogen, in volunteer subjects. Compr Psychiatry 1:8\u201317","journal-title":"Compr Psychiatry"},{"key":"457_CR23","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/cpt1971122part1245","volume":"12","author":"WR Martin","year":"1971","unstructured":"Martin WR, Sloan JW, Sapira JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245\u2013258","journal-title":"Clin Pharmacol Ther"},{"key":"457_CR24","volume-title":"The varieties of psychedelic experience","author":"REL Masters","year":"1966","unstructured":"Masters REL, Houston J (1966) The varieties of psychedelic experience. Holt Rinehart & Winston, New York"},{"key":"457_CR25","volume-title":"Teonanacatl: sacred mushroom of visions","author":"R Metzner","year":"2004","unstructured":"Metzner R (2004) Teonanacatl: sacred mushroom of visions. Four Tree, El Verano, CA"},{"key":"457_CR26","first-page":"3","volume":"5","author":"R Metzner","year":"1965","unstructured":"Metzner R, Litwin G, Weil G (1965) The relation of expectation and mood to psilocybin reactions: a questionnaire study. Psychedelic Rev 5:3\u201339","journal-title":"Psychedelic Rev"},{"key":"457_CR27","unstructured":"National Institute on Drug Abuse (2001) Hallucinogens and dissociative drugs. National Institute on Drug Abuse research report series, NIH publication, volume 01-4209"},{"key":"457_CR28","volume-title":"LSD NIDA infofacts","author":"National Institute on Drug Abuse","year":"2005","unstructured":"National Institute on Drug Abuse (2005) LSD NIDA infofacts. National Institute on Drug Abuse, Rockville, MD, February 2005"},{"key":"457_CR29","unstructured":"Pahnke W (1963) Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness. Ph.D. thesis, Harvard University"},{"key":"457_CR30","first-page":"60","volume-title":"LSD man & society","author":"WN Pahnke","year":"1967","unstructured":"Pahnke WN (1967) LSD and religious experience. In: DeBold RC, Leaf RC (eds) LSD man & society. Wesleyan University Press, Middletown, CT, pp 60\u201385"},{"key":"457_CR31","first-page":"149","volume":"5","author":"WN Pahnke","year":"1969","unstructured":"Pahnke WN (1969) Psychedelic drugs and mystical experience. Int Psychiatry Clin 5:149\u2013162","journal-title":"Int Psychiatry Clin"},{"key":"457_CR32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/1467-6494.00080","volume":"67","author":"RL Piedmont","year":"1999","unstructured":"Piedmont RL (1999) Does spirituality represent the sixth factor of personality? Spiritual transcendence and the five-factor model. J Person 67:985\u20131013","journal-title":"J Person"},{"key":"457_CR33","unstructured":"Piedmont RL (2005) Aspires assessment of spirituality and religious sentiments. Technical Manual, Loyola College in Maryland, Columbia, MD"},{"key":"457_CR34","doi-asserted-by":"crossref","unstructured":"Piedmont RL (2006) Cross-cultural generalizability of the Spiritual Transcendence Scale to the Philippines: spirituality as a universal. Ment Health Relig Cult (In press)","DOI":"10.1080\/13694670500275494"},{"key":"457_CR35","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1177\/0002764202045012011","volume":"45","author":"RL Piedmont","year":"2002","unstructured":"Piedmont RL, Leach MM (2002) Cross-cultural generalizability of the spiritual transcendence scale in India. Am Behav Sci 45:1886\u20131899","journal-title":"Am Behav Sci"},{"key":"457_CR36","first-page":"89","volume-title":"Teonanacatl","author":"DE Presti","year":"2004","unstructured":"Presti DE, Nichols DE (2004) Biochemistry and neuropharmacology of psilocybin mushrooms. In: Metzner R, Darling DC (eds) Teonanacatl. Four Trees, El Verano, CA, pp 89\u2013108"},{"key":"457_CR37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(00)00175-7","volume":"62","author":"J Riba","year":"2001","unstructured":"Riba J, Rodriguez-Fornells A, Strassman RJ, Barbanoj MJ (2001) Psychometric assessment of the Hallucinogen Rating Scale. Drug Alcohol Depend 62:215\u2013223","journal-title":"Drug Alcohol Depend"},{"key":"457_CR38","unstructured":"Richards WA (1975) Counseling, peak experiences and the human encounter with death: an empirical study of the efficacy of DPT-assisted counseling in enhancing the quality of life of persons with terminal cancer and their closest family members. Ph.D. thesis, Catholic University of America, Washington, DC"},{"key":"457_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.1977.10472020","volume":"9","author":"WA Richards","year":"1977","unstructured":"Richards WA, Rhead JC, DiLeo FB, Yensen R, Kurland AA (1977) The peak experience variable in DPT-assisted psychotherapy with cancer patients. J Psychedelic Drugs 9:1\u201310","journal-title":"J Psychedelic Drugs"},{"key":"457_CR40","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1056\/NEJM196002112620606","volume":"262","author":"M Rinkel","year":"1960","unstructured":"Rinkel M, Atwell CR, Dimascio A, Brown J (1960) Experimental psychiatry. V. Psilocybine, a new psychotogenic drug. N Engl J Med 262:295\u2013297","journal-title":"N Engl J Med"},{"key":"457_CR41","volume-title":"Psychoactive sacramentals: essays on entheogens and religion","author":"TB Roberts","year":"2001","unstructured":"Roberts TB (2001) Psychoactive sacramentals: essays on entheogens and religion. Council on Spiritual Practices, San Francisco, CA"},{"key":"457_CR42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/BF00413244","volume":"5","author":"DE Rosenberg","year":"1964","unstructured":"Rosenberg DE, Isbell H, Miner EJ, Logan CR (1964) The effect of N, N-dimethyltryptamine in human subjects tolerant to lysergic acid diethylamide. Psychopharmacologia 5:217\u2013227","journal-title":"Psychopharmacologia"},{"key":"457_CR43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1037\/1064-1297.6.1.32","volume":"6","author":"CR Rush","year":"1998","unstructured":"Rush CR, Kollins SH, Pazzaglia PJ (1998) Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans. Exp Clin Psychopharmacol 6:32\u201344","journal-title":"Exp Clin Psychopharmacol"},{"key":"457_CR44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2307\/2023494","volume":"61","author":"H Smith","year":"1964","unstructured":"Smith H (1964) Do drugs have religious import? J Philos 61:517\u2013530","journal-title":"J Philos"},{"key":"457_CR45","volume-title":"Cleansing the doors of perception: the religious significance of entheogenic plants and chemicals","author":"H Smith","year":"2000","unstructured":"Smith H (2000) Cleansing the doors of perception: the religious significance of entheogenic plants and chemicals. Tarcher\/Putnam, New York"},{"key":"457_CR46","volume-title":"The psychology of religion: an empirical approach","author":"B Spilka","year":"2005","unstructured":"Spilka B, Hood RW, Hunsberger B, Gorsuch R (2005) The psychology of religion: an empirical approach, 3rd edn. Guilford, New York","edition":"3rd edn"},{"key":"457_CR47","volume-title":"Mysticism and philosophy","author":"WT Stace","year":"1960","unstructured":"Stace WT (1960) Mysticism and philosophy. Lippincott, Philadelphia"},{"key":"457_CR48","volume-title":"Psilocybin mushrooms of the world: an identification guide","author":"P Stamets","year":"1996","unstructured":"Stamets P (1996) Psilocybin mushrooms of the world: an identification guide. Ten Speed, Berkeley, CA"},{"key":"457_CR49","volume-title":"Psychoactive sacramentals: essays on entheogens and religion","author":"MJ Stolaroff","year":"2001","unstructured":"Stolaroff MJ (2001) A protocol for a sacramental service. In: Roberts TB (ed) Psychoactive sacramentals: essays on entheogens and religion. Council on Spiritual Practices, San Francisco, CA"},{"key":"457_CR50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archpsyc.1994.03950020022002","volume":"51","author":"RJ Strassman","year":"1994","unstructured":"Strassman RJ, Qualls CR, Uhlenhuth EH, Kellner R (1994) Dose\u2013response study of N, N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale. Arch Gen Psychiatry 51:98\u2013108","journal-title":"Arch Gen Psychiatry"},{"key":"457_CR51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/02791072.1974.10471499","volume":"6","author":"IS Turek","year":"1974","unstructured":"Turek IS, Soskin RA, Kurland AA (1974) Methylenedioxyamphetamine (MDA) subjective effects. J Psychedelic Drugs 6:7\u201314","journal-title":"J Psychedelic Drugs"},{"key":"457_CR52","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","volume":"9","author":"FX Vollenweider","year":"1998","unstructured":"Vollenweider FX, Vollenweider-Scherpenhuyzen MFI, Babler A, Vogel H, Hell D (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport 9:3897\u20133902","journal-title":"Neuroreport"},{"key":"457_CR53","volume-title":"The wondrous mushroom: mycolatry in Mesoamerica","author":"RG Wasson","year":"1980","unstructured":"Wasson RG (1980) The wondrous mushroom: mycolatry in Mesoamerica. McGraw-Hill, New York"},{"key":"457_CR54","volume-title":"The PANAS-X manual for the positive and negative affect schedule\u2014expanded form","author":"D Watson","year":"1994","unstructured":"Watson D, Clark LA (1994) The PANAS-X manual for the positive and negative affect schedule\u2014expanded form. The University of Iowa, Iowa City, Iowa"},{"key":"457_CR55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1207\/s15327752jpa6802_4","volume":"68","author":"D Watson","year":"1997","unstructured":"Watson D, Clark LA (1997) Measurement and mismeasurement of mood: recurrent and emergent issues. J Pers Assess 68:267\u2013296","journal-title":"J Pers Assess"},{"key":"457_CR56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00412109","volume":"3","author":"AB Wolbach Jr","year":"1962","unstructured":"Wolbach AB Jr, Miner EJ, Isbell H (1962) Comparison of psilocin with psilocybin, mescaline and LSD-25. Psychopharmacologia 3:219\u2013223","journal-title":"Psychopharmacologia"},{"key":"457_CR57","volume-title":"Psychology of religion; classic and contemporary views","author":"DM Wulff","year":"1991","unstructured":"Wulff DM (1991) Psychology of religion; classic and contemporary views. Wiley, New York"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0457-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-006-0457-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-006-0457-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T12:31:25Z","timestamp":1558614685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-006-0457-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,7]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["457"],"URL":"https:\/\/doi.org\/10.1007\/s00213-006-0457-5","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1040591.496273","asserted-by":"object"}]},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,7]]}}}